Market Research

Cannabinoids Market (Product Type: Cannabinoids, Tetrahydrocannabinol, Cannabinol, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 190 Pages Transparency Market Research Pvt. Ltd. May, 2022 TNPR17326565
Best Price Guarantee
Price from $5,795
Length 190 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date May, 2022
SKU TNPR17326565

Cannabinoids Market (Product Type: Cannabinoids, Tetrahydrocannabinol, Cannabinol, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Companies Mentioned

Mylan N.V. (Viatris Inc.)
Alkem Labs
GW Pharmaceuticals plc
Tilray, Inc.
Aurora Cannabis, Inc.
Canopy Growth Corporation
The Cronos Group

Countries

North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Forecast Year (first) - 2022

Forecast Year (last) - 2031

Forecast Year ( first)  Value - 22.1

Forecast Year (last) Value - 154.2

CAGR % - 0.222

Currency - US$ Bn


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cannabinoids Market
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Global Cannabinoids Market Analysis and Forecast, 2017–2031
4.3.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Porter's Five Forces Analysis
5.2. PESTLE Analysis
5.3. Cannabis Genetics: Overview & Analysis
5.4. Regulatory Scenario, by Region/Globally
5.5. Pricing Analysis
5.6. List of key Competitors
5.7. COVID-19 Impact Analysis
5.8. Key Industry Development
6. Global Cannabinoids Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Cannabidiol
6.3.2. Tetrahydrocannabinol
6.3.3. Cannabinol
6.3.4. Others
6.4. Market Attractiveness Analysis, by Product Type
7. Global Cannabinoids Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Distribution Channel, 2017–2031
7.3.1. Hospitals Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Online Stores
7.4. Market Attractiveness Analysis, by Distribution Channel
8. Global Cannabinoids Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2017–2031
8.3.1. Medicinal Use
8.3.1.1. Chronic Pain
8.3.1.2. Neurological Disorders Management
8.3.1.3. Oncology
8.3.1.4. Others
8.3.2. Non-medical Use
8.4. Market Attractiveness Analysis, by Application
9. Global Cannabinoids Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Cannabinoids Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Cannabidiol
10.2.2. Tetrahydrocannabinol
10.2.3. Cannabinol
10.2.4. Others
10.3. Market Value Forecast, by Distribution Channel, 2017–2031
10.3.1. Hospitals Pharmacies
10.3.2. Retail Pharmacies
10.3.3. Online Stores
10.4. Market Value Forecast, by Application, 2017–2031
10.4.1. Medicinal Use
10.4.1.1. Chronic Pain
10.4.1.2. Neurological Disorders Management
10.4.1.3. Oncology
10.4.1.4. Others
10.4.2. Non-medical Use
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product Type
10.6.2. By Distribution Channel
10.6.3. By Application
10.6.4. By Country
11. Europe Cannabinoids Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Cannabidiol
11.2.2. Tetrahydrocannabinol
11.2.3. Cannabinol
11.2.4. Others
11.3. Market Value Forecast, by Distribution Channel, 2017–2031
11.3.1. Hospitals Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Stores
11.4. Market Value Forecast, by Application, 2017–2031
11.4.1. Medicinal Use
11.4.1.1. Chronic Pain
11.4.1.2. Neurological Disorders Management
11.4.1.3. Oncology
11.4.1.4. Others
11.4.2. Non-medical Use
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Distribution Channel
11.6.3. By Application
11.6.4. By Country/Sub-region
12. Asia Pacific Cannabinoids Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Cannabidiol
12.2.2. Tetrahydrocannabinol
12.2.3. Cannabinol
12.2.4. Others
12.3. Market Value Forecast, by Distribution Channel, 2017–2031
12.3.1. Hospitals Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Stores
12.4. Market Value Forecast, by Application, 2017–2031
12.4.1. Medicinal Use
12.4.1.1. Chronic Pain
12.4.1.2. Neurological Disorders Management
12.4.1.3. Oncology
12.4.1.4. Others
12.4.2. Non-medical Use
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. Japan
12.5.2. India
12.5.3. Australia & New Zealand
12.5.4. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Distribution Channel
12.6.3. By Application
12.6.4. By Country/Sub-region
13. Latin America Cannabinoids Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Cannabidiol
13.2.2. Tetrahydrocannabinol
13.2.3. Cannabinol
13.2.4. Others
13.3. Market Value Forecast, by Distribution Channel, 2017–2031
13.3.1. Hospitals Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Stores
13.4. Market Value Forecast, by Application, 2017–2031
13.4.1. Medicinal Use
13.4.1.1. Chronic Pain
13.4.1.2. Neurological Disorders Management
13.4.1.3. Oncology
13.4.1.4. Others
13.4.2. Non-medical Use
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product Type
13.6.2. By Distribution Channel
13.6.3. By Application
13.6.4. By Country/Sub-region
14. Middle East & Africa Cannabinoids Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Cannabidiol
14.2.2. Tetrahydrocannabinol
14.2.3. Cannabinol
14.2.4. Others
14.3. Market Value Forecast, by Distribution Channel, 2017–2031
14.3.1. Hospitals Pharmacies
14.3.2. Retail Pharmacies
14.3.3. Online Stores
14.4. Market Value Forecast, by Application, 2017–2031
14.4.1. Medicinal Use
14.4.1.1. Chronic Pain
14.4.1.2. Neurological Disorders Management
14.4.1.3. Oncology
14.4.1.4. Others
14.4.2. Non-medical Use
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. South Africa
14.5.2. Israel
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Product Type
14.6.2. By Distribution Channel
14.6.3. By Application
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Company Profiles
15.2.1. Mylan N.V. (Viatris Inc.)
15.2.1.1. Company Overview
15.2.1.2. Financial Overview
15.2.1.3. Product Portfolio
15.2.1.4. Business Strategies
15.2.1.5. Recent Developments
15.2.2. Alkem Labs
15.2.2.1. Company Overview
15.2.2.2. Financial Overview
15.2.2.3. Product Portfolio
15.2.2.4. Business Strategies
15.2.2.5. Recent Developments
15.2.3. GW Pharmaceuticals plc
15.2.3.1. Company Overview
15.2.3.2. Financial Overview
15.2.3.3. Product Portfolio
15.2.3.4. Business Strategies
15.2.3.5. Recent Developments
15.2.4. Tilray, Inc.
15.2.4.1. Company Overview
15.2.4.2. Financial Overview
15.2.4.3. Product Portfolio
15.2.4.4. Business Strategies
15.2.4.5. Recent Developments
15.2.5. Aurora Cannabis, Inc.
15.2.5.1. Company Overview
15.2.5.2. Financial Overview
15.2.5.3. Product Portfolio
15.2.5.4. Business Strategies
15.2.5.5. Recent Developments
15.2.6. Canopy Growth Corporation
15.2.6.1. Company Overview
15.2.6.2. Financial Overview
15.2.6.3. Product Portfolio
15.2.6.4. Business Strategies
15.2.6.5. Recent Developments
15.2.7. The Cronos Group
15.2.7.1. Company Overview
15.2.7.2. Financial Overview
15.2.7.3. Product Portfolio
15.2.7.4. Business Strategies
15.2.7.5. Recent Developments

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings